The U.S. healthcare system presents a paradox: It’s the most expensive system in the world, and yet it produces among the worst results among developed countries.

Teva Pharmaceutical Industries announced the launch of an authorized generic of a Type 2 diabetes drug.

A division of Teva Pharmaceutical Industries has launched a generic chemotherapy drug, the company said.

An experimental drug therapy under development by Novartis for liver transplant patients appears to provide similar efficacy and better kidney function, compared with a drug made by Astellas Pharma, according to results of a late-stage clinical trial.

Mylan has launched a generic drug used to treat sleep disorders, the company said Friday.

Hospira has relaunched a generic chemotherapy drug for the U.S. market, the generic drug maker said Thursday.

Bristol-Myers Squibb has bought a majority stake in drug maker Amylin Pharmaceuticals, Bristol said Wednesday.

A biotech drug made by Eli Lilly for osteoporosis appeared no more or less effective than a pharmaceutical drug available as a generic in treating women with related bone fractures, but was more effective in some other measures, according to results of a late-stage clinical trial released Tuesday.

The Food and Drug Administration has approved several generic versions of a drug used to treat asthma and allergies, the agency said Friday.

Winn-Dixie announced the generic form of Plavix (clopidogrel) now is available for $4 for 30-day and $10 for 90-day prescriptions as part of the company's prescription savings program.

Use of generic drugs has saved consumers and the healthcare system $1 trillion over the past decade, according to a new study released Thursday by a generic drug industry trade organization.

The Food and Drug Administration has approved a generic drug designed to treat asthma in children.